Back to search

Article

Aberrant TNF signaling in pancreatic lymph nodes of patients with Type 1 Diabetes

2024-06-03

Abstract excerpt

The therapeutic landscape for Type 1 Diabetes (T1D) is rapidly changing as ongoing clinical trials aim to delay beta-cell loss by inhibiting proinflammatory cytokines. However, the precise timing and cellular contexts of cytokine dysregulation remains unknown. We generated the largest existing measurement of gene expression and chromatin accessibility in ∼1 million immune cells from the pancreatic lymph nodes and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3c65a0af-02ae-57b1-93c4-974be6b4ee2c
DOI
10.1101/2024.05.31.596885
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Aberrant TNF signaling in pancreatic lymph nodes of patients with Type 1 DiabetesDOI 10.1101/2024.05.31.596885
Select a neighboring publication to make it the new centre.